4th TGF-B Targeted Drug Development Summit
-
Location:
- The Clift Royal Sonesta San Francisco
- 495 Geary Street
- San Francisco
- California
- 94102
- United States
- View on a map
- More Information:
-
Contact:
- Organiser: Hanson Wade
- Name: Isabel Weir
- Email: info@hansonwade.com
- Telephone: +16174554188
With 128 TGF-B targeted therapies in the clinic and 68 in the preclinical stage, the TGF-B field is currently being rejuvenated by novel approaches in immuno-oncology, and cutting edge research in fibrosis, autoimmune diseases, and beyond.
The TGF-B Targeted Drug Development Summit returns to San Francisco for the 4th year to deep dive into the hottest topics in the field, such as combination strategies being employed by Genentech and discovering new and predictive biomarkers from Corbus Pharmaceuticals. This meeting will support you in securing clinical success with safe and efficacious TGF-B targeted therapies.
With a program consisting of TGF-B industry leaders such as Cue Biopharma, Synthis, and Pfizer, this year promises to spotlight innovative ways biotech and large pharma companies are overcoming toxicity, translation, and proving clinical efficacy. Join us in October to celebrate the accomplishments of the TGF-B field and anticipate the future towards clinically effective and approved TGF-B targeted therapies.
Date and Time: Tuesday, 15 October 2024 at 09:00 to Thursday, 17 October 2024 at 17:00
